Evaluation of the Multiple Sclerosis Spasticity Scale 88: A Short Report.
multiple sclerosis
outcome assessment
psychometrics
spasticity
Journal
Rehabilitation process and outcome
ISSN: 1179-5727
Titre abrégé: Rehabil Process Outcome
Pays: England
ID NLM: 101774452
Informations de publication
Date de publication:
2019
2019
Historique:
received:
02
11
2018
accepted:
12
11
2018
entrez:
9
9
2021
pubmed:
16
1
2019
medline:
16
1
2019
Statut:
epublish
Résumé
The Multiple Sclerosis Spasticity Scale 88 (MSSS-88) is designed to capture the patient experience and impact of spasticity, but there is limited evaluation against clinician-rated measures of spasticity. To evaluate the convergent validity and responsiveness of the MSSS-88. Longitudinal study. University Laboratory. Thirty-four people with multiple sclerosis. People with multiple sclerosis (MS; n = 34) completed the self-reported 12-item Multiple Sclerosis Walking Scale, Multiple Sclerosis Spasticity Scale, Barthel Index alongside the clinician-rated Ashworth Scale, and a laboratory-based measure of ankle spasticity. Spasticity measure responsiveness was evaluated in 20 participants at two time points, an average of 8.75 ± 3.8 months apart. In people with MS (mean age 55.1 ± 8.1 years; Expanded Disability Scale range 4.5-7.0), spasticity symptom specific subscales of the MSSS-88 (stiffness and spasms) showed strong and significant correlations with the clinician-rated Ashworth Scale ( Our findings lend additional support to the convergent validity of this measure.
Sections du résumé
BACKGROUND
BACKGROUND
The Multiple Sclerosis Spasticity Scale 88 (MSSS-88) is designed to capture the patient experience and impact of spasticity, but there is limited evaluation against clinician-rated measures of spasticity.
OBJECTIVE
OBJECTIVE
To evaluate the convergent validity and responsiveness of the MSSS-88.
DESIGN
METHODS
Longitudinal study.
SETTING
METHODS
University Laboratory.
SUBJECTS
METHODS
Thirty-four people with multiple sclerosis.
METHODS
METHODS
People with multiple sclerosis (MS; n = 34) completed the self-reported 12-item Multiple Sclerosis Walking Scale, Multiple Sclerosis Spasticity Scale, Barthel Index alongside the clinician-rated Ashworth Scale, and a laboratory-based measure of ankle spasticity. Spasticity measure responsiveness was evaluated in 20 participants at two time points, an average of 8.75 ± 3.8 months apart.
RESULTS
RESULTS
In people with MS (mean age 55.1 ± 8.1 years; Expanded Disability Scale range 4.5-7.0), spasticity symptom specific subscales of the MSSS-88 (stiffness and spasms) showed strong and significant correlations with the clinician-rated Ashworth Scale (
CONCLUSIONS
CONCLUSIONS
Our findings lend additional support to the convergent validity of this measure.
Identifiants
pubmed: 34497457
doi: 10.1177/1179572718823510
pii: 10.1177_1179572718823510
pmc: PMC8276976
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1179572718823510Informations de copyright
© The Author(s) 2019.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
BMC Neurol. 2010 Oct 07;10:88
pubmed: 20929556
Disabil Rehabil. 2019 Feb;41(4):465-471
pubmed: 29069950
PLoS One. 2016 Jan 15;11(1):e0147042
pubmed: 26771661
Health Qual Life Outcomes. 2014 Aug 01;12:119
pubmed: 25080934
Brain. 2006 Jan;129(Pt 1):224-34
pubmed: 16280352
Practitioner. 1964 Apr;192:540-2
pubmed: 14143329
Neurology. 2003 Jan 14;60(1):31-6
pubmed: 12525714
Clin Biomech (Bristol, Avon). 2016 Aug;37:22-26
pubmed: 27286554
Expert Rev Neurother. 2011 Apr;11(4 Suppl):3-8
pubmed: 21449853
Value Health. 2007 Nov-Dec;10 Suppl 2:S94-S105
pubmed: 17995479